Lufei Sui

ORCID: 0000-0002-7100-7328
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Peptidase Inhibition and Analysis
  • Wnt/β-catenin signaling in development and cancer
  • Angiogenesis and VEGF in Cancer
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Biochemical and Molecular Research
  • Cancer Cells and Metastasis
  • Galectins and Cancer Biology
  • Lymphatic System and Diseases
  • Mechanisms of cancer metastasis
  • Cancer-related gene regulation
  • Clostridium difficile and Clostridium perfringens research
  • Epigenetics and DNA Methylation
  • Ferroptosis and cancer prognosis
  • Metabolism and Genetic Disorders
  • Botany, Ecology, and Taxonomy Studies
  • Axon Guidance and Neuronal Signaling
  • Cancer, Hypoxia, and Metabolism
  • Adenosine and Purinergic Signaling
  • Protease and Inhibitor Mechanisms
  • Lysosomal Storage Disorders Research
  • Genomics and Chromatin Dynamics
  • Ubiquitin and proteasome pathways
  • Cellular transport and secretion
  • Yeasts and Rust Fungi Studies
  • Hippo pathway signaling and YAP/TAZ

Boston Children's Hospital
2020-2023

Harvard University
2020-2022

University of Massachusetts Lowell
2014-2021

Boston Children's Museum
2020

University of Hawaii System
1997

Abstract We have synthesized an oxetane derivative of the benzimidazole compound mebendazole (OBD9) with enhanced solubility and strong anticancer activity in multiple types cancer cells, especially colorectal cancer. In this report, we provide evidence that OBD9 suppresses growth by interfering Wnt signaling pathway, a main driver cell Specifically, find induces autophagic degradation TNIK (traf2 Nck-interacting kinase), which promotes T-cell factor-4 (TCF4)/beta-catenin–mediated gene...

10.1158/1535-7163.mct-21-0801 article EN Molecular Cancer Therapeutics 2022-10-27

The progression of cancer from localized to metastatic disease is the primary cause morbidity and mortality. interplay between tumor its microenvironment key driver in this process progression. In order for tumors progress metastasize they must reprogram cells that make up promote growth suppress endogenous defense systems, such as immune inflammatory response. We have previously demonstrated stimulation Tsp-1 (TME) potently inhibits Here, we identify a novel tumor-mediated mechanism...

10.1038/s41467-022-35649-9 article EN cc-by Nature Communications 2022-12-27

Wnt signaling pathways are transmitted via 10 homologous frizzled receptors (FZD1-10) in humans. Reagents broadly inhibiting reduce growth and metastasis of many tumors, but their therapeutic development has been hampered by the side effect. Inhibitors targeting specific Wnt-FZD pair(s) enriched cancer cells may effect, effect narrow-spectrum inhibitors remains to be established vivo. Here, we developed a fragment C . difficile toxin B (TcdB FBD ), which recognizes inhibits subclass FZDs,...

10.1371/journal.pbio.3002353 article EN cc-by PLoS Biology 2023-11-09

Human endoplasmic reticulum aminopeptidase 1 (ERAP1) is one of two ER luminal aminopeptidases that participate in the final processing peptide precursors and generates N-termini MHC class I-restricted epitopes. In order to investigate interactions its binding site with substrate peptides, X-ray crystallographic analyses have been carried out study structures ERAP1 regulatory (ERAP1_R) domain complex antigenic peptides. Single-chain bimodular constructs various peptides linked C-terminal end...

10.4236/csta.2015.44006 article EN Crystal Structure Theory and Applications 2015-01-01

Abstract Current treatment of triple negative breast cancer patients is hindered by a high incidence chemoresistance (30-50%). The prevailing theory that resistance and subsequent recurrence driven stem cells. Unfortunately, the functional characterization cells at molecular level still incomplete. We show here, within canonical cell population, subset characterized Notch1 expression possesses tumor-initiating property associated with Moreover, tumor initiating these Notch1-expressing...

10.1101/2020.02.28.970764 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2020-02-29

Abstract In the earliest stages of tumor development, epithelial tumors (carcinomas) are physically confined to area tissue in which they form. These nascent lesions (carcinomas situ) sequestered from parenchyma by basement membrane. Within lie a myriad cell types comprised fibroblasts, immune and inflammatory cells endothelial cells. Upon invasion across membrane into parenchyma, must manipulate expression pro- anti-tumorigenic proteins such that pro-tumorigenic factors produced excess...

10.1101/2021.03.23.436667 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2021-03-23

Insulin-regulated aminopeptidase (IRAP) in humans is a membrane bound enzyme that has multiple functions. It was first described as companion protein of the insulin-responsive glucose transporter, Glut4, specialized vesicles. The subsequently been shown to be identical oxytocinase/aminopeptidase or angiotensin IV (Ang IV) receptor (AT4 receptor). Some AT4 ligand peptides, such Ang and LVV-hemorphin-7, have act IRAP inhibitors exert memory-enhancing properties. As target for developing...

10.1016/j.bbrep.2021.101042 article EN cc-by-nc-nd Biochemistry and Biophysics Reports 2021-06-09

Abstract BRCA1 germ-line mutations are a major cause of hereditary breast cancer and BRCA1-deficient shares many characteristics as sporadic basal-like (BLBC). Effective therapeutic targets for BLBC remain lacking. By utilizing mouse model based on intraductal injection Krt8-Cre adenovirus to inactivate Brca1 Trp53 in luminal mammary epithelial cells, here we report that the Wnt receptor Frizzled 7 (FZD7) serves biomarker target resulting tumor cells is particularly enriched stem /...

10.21203/rs.3.rs-58989/v1 preprint EN cc-by Research Square (Research Square) 2020-08-31

<div>Abstract<p>We have synthesized an oxetane derivative of the benzimidazole compound mebendazole (OBD9) with enhanced solubility and strong anticancer activity in multiple types cancer cells, especially colorectal cancer. In this report, we provide evidence that OBD9 suppresses growth by interfering Wnt signaling pathway, a main driver cell Specifically, find induces autophagic degradation TNIK (traf2 Nck-interacting kinase), which promotes T-cell factor-4...

10.1158/1535-7163.c.6543706 preprint EN 2023-04-03

<div>Abstract<p>We have synthesized an oxetane derivative of the benzimidazole compound mebendazole (OBD9) with enhanced solubility and strong anticancer activity in multiple types cancer cells, especially colorectal cancer. In this report, we provide evidence that OBD9 suppresses growth by interfering Wnt signaling pathway, a main driver cell Specifically, find induces autophagic degradation TNIK (traf2 Nck-interacting kinase), which promotes T-cell factor-4...

10.1158/1535-7163.c.6543706.v1 preprint EN 2023-04-03

Oral squamous cell carcinoma (OSCC) accounts for the majority of all oral malignancies. The overall survival rate patients diagnosed with advanced‐stage OSCC (with metastasis) is only 39%, and prognosis these has not improved dramatically despite advances in chemotherapeutic, radiotherapeutic, surgical protocols. As such, there remains an urgent need to develop new therapies improve outcome. Recently, our laboratory identified Neuropilin‐2 (NRP2) transmembrane receptor as a novel target its...

10.1096/fasebj.2020.34.s1.02668 article EN The FASEB Journal 2020-04-01

Oral squamous cell carcinoma (OSCC) is the sixth most common cancer worldwide. The majority (67%) of patients with this aggressive already exhibit local or distant metastases at time initial diagnosis. Understanding molecular mechanisms that regulate OSCC progression and metastasis paramount to developing novel therapeutic strategies for disease. Enhanced tumor‐associated lymphangiogenesis correlates increased lymph node adversely affects prognosis in OSCC. Neuropilin 2 (NRP2) an endothelial...

10.1096/fasebj.2020.34.s1.02389 article EN The FASEB Journal 2020-04-01

Abstract Current treatment of triple negative breast cancer is hindered by a high incidence chemoresistance (30-50%). The prevailing theory that resistance and subsequent recurrence driven stem cells. Unfortunately, the functional characterization cells at molecular level still incomplete. We show here, within canonical cell population (CD24low/CD44+/ESA+) cells, subset characterized Notch1 expression possesses tumor-initiating properties associated with Moreover, tumor initiating property...

10.1158/1538-7445.am2020-4963 article EN Cancer Research 2020-08-15
Coming Soon ...